MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ALPMY
  4. News
ALPMY
Quote
Short
News
Articles
Message Board

Astellas Pharma Inc. ADR (OTCMKTS : ALPMY ) News

Astellas Pharma Inc. ADR (OTCMKTS: ALPMY) News Releases

ALPMY News Releases
ALPMY : OTC
SeekingAlpha
Merck's Keytruda shows overall survival benefit in ovarian cancer
ALPMY : OTC
SeekingAlpha
Bayer says Xofigo/Xtandi combo shows overall survival benefit in prostate cancer
ALPMY : OTC
SeekingAlpha
Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset
ALPMY : OTC
SeekingAlpha
China drug licensing deals surge nearly 10-fold in value since 2021
ALPMY : OTC
SeekingAlpha
AstraZeneca, Bristol partner with Evinova to use AI in drug development
ALPMY : OTC
SeekingAlpha
Astellas Pharma ADR GAAP EPS of ¥185.20, revenue of ¥1601.32B; updates full-year forecast
ALPMY : OTC
SeekingAlpha
Belite Bio On A Tear As It Approaches Key Regulatory Submissions
ALPMY : OTC
SeekingAlpha
MRNA is S&P 500's top performing stock, here are the best Quant pharma companies
ALPMY : OTC
SeekingAlpha
Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ALPMY : OTC
PR Newswire
VYLOY(TM) (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.